GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
葛兰素史克葛兰素史克(US:GSK) WSJ·2026-01-20 15:48

并购交易核心条款 - 制药公司同意以每股58美元的价格收购RAPT Therapeutics股东所持股份 [1] - 交易包含19亿美元现金形式的前期投资 [1]

GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments - Reportify